BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 17597105)

  • 1. Aldo-keto reductase family 1 B10 gene silencing results in growth inhibition of colorectal cancer cells: Implication for cancer intervention.
    Yan R; Zu X; Ma J; Liu Z; Adeyanju M; Cao D
    Int J Cancer; 2007 Nov; 121(10):2301-6. PubMed ID: 17597105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aldo-keto reductase 1B10 protects human colon cells from DNA damage induced by electrophilic carbonyl compounds.
    Zu X; Yan R; Pan J; Zhong L; Cao Y; Ma J; Cai C; Huang D; Liu J; Chung FL; Liao DF; Cao D
    Mol Carcinog; 2017 Jan; 56(1):118-129. PubMed ID: 26969882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aldo-keto reductase family 1 member B10 promotes cell survival by regulating lipid synthesis and eliminating carbonyls.
    Wang C; Yan R; Luo D; Watabe K; Liao DF; Cao D
    J Biol Chem; 2009 Sep; 284(39):26742-8. PubMed ID: 19643728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aldo-keto reductase family 1 B10 affects fatty acid synthesis by regulating the stability of acetyl-CoA carboxylase-alpha in breast cancer cells.
    Ma J; Yan R; Zu X; Cheng JM; Rao K; Liao DF; Cao D
    J Biol Chem; 2008 Feb; 283(6):3418-3423. PubMed ID: 18056116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibiting proliferation and migration of lung cancer using small interfering RNA targeting on Aldo-keto reductase family 1 member B10.
    Zhou Z; Zhao Y; Gu L; Niu X; Lu S
    Mol Med Rep; 2018 Feb; 17(2):2153-2160. PubMed ID: 29207124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AKR1B10, a transcriptional target of p53, is downregulated in colorectal cancers associated with poor prognosis.
    Ohashi T; Idogawa M; Sasaki Y; Suzuki H; Tokino T
    Mol Cancer Res; 2013 Dec; 11(12):1554-63. PubMed ID: 24140838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression and oncogenic function of aldo-keto reductase family 1B10 (AKR1B10) in pancreatic carcinoma.
    Chung YT; Matkowskyj KA; Li H; Bai H; Zhang W; Tsao MS; Liao J; Yang GY
    Mod Pathol; 2012 May; 25(5):758-66. PubMed ID: 22222635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure and promoter characterization of aldo-keto reductase family 1 B10 gene.
    Liu Z; Zhong L; Krishack PA; Robbins S; Cao JX; Zhao Y; Chung S; Cao D
    Gene; 2009 May; 437(1-2):39-44. PubMed ID: 19236911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown or inhibition of aldo-keto reductase 1B10 inhibits pancreatic carcinoma growth via modulating Kras-E-cadherin pathway.
    Zhang W; Li H; Yang Y; Liao J; Yang GY
    Cancer Lett; 2014 Dec; 355(2):273-80. PubMed ID: 25304374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of aldo-keto reductase family 1 member B10 on the risk of hepatitis C virus-related hepatocellular carcinoma.
    Sato S; Genda T; Ichida T; Murata A; Tsuzura H; Narita Y; Kanemitsu Y; Ishikawa S; Kikuchi T; Mori M; Hirano K; Iijima K; Wada R; Nagahara A; Watanabe S
    J Gastroenterol Hepatol; 2016 Jul; 31(7):1315-22. PubMed ID: 26758591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aldo-keto reductase family 1 B10 protein detoxifies dietary and lipid-derived alpha, beta-unsaturated carbonyls at physiological levels.
    Zhong L; Liu Z; Yan R; Johnson S; Zhao Y; Fang X; Cao D
    Biochem Biophys Res Commun; 2009 Sep; 387(2):245-50. PubMed ID: 19563777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulindac inhibits pancreatic carcinogenesis in LSL-KrasG12D-LSL-Trp53R172H-Pdx-1-Cre mice via suppressing aldo-keto reductase family 1B10 (AKR1B10).
    Li H; Yang AL; Chung YT; Zhang W; Liao J; Yang GY
    Carcinogenesis; 2013 Sep; 34(9):2090-8. PubMed ID: 23689354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aldo-Keto Reductases as Early Biomarkers of Hepatocellular Carcinoma: A Comparison Between Animal Models and Human HCC.
    Torres-Mena JE; Salazar-Villegas KN; Sánchez-Rodríguez R; López-Gabiño B; Del Pozo-Yauner L; Arellanes-Robledo J; Villa-Treviño S; Gutiérrez-Nava MA; Pérez-Carreón JI
    Dig Dis Sci; 2018 Apr; 63(4):934-944. PubMed ID: 29383608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of aldo-keto reductase AKR1B10 gene expression by a phorbol ester via the ERK/c-Jun signaling pathway.
    Nishinaka T; Miura T; Sakou M; Hidaka C; Sasaoka C; Okamura A; Okamoto A; Terada T
    Chem Biol Interact; 2015 Jun; 234():274-81. PubMed ID: 25463304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of AKR1B10 gene silence on the growth and gene expression of HCC cell line MHCC97H].
    Wei W; Liang HJ; Cui JF; Guo K; Kang XN; Cao J; Su JJ; Li Y; Liu YK
    Zhonghua Gan Zang Bing Za Zhi; 2010 Sep; 18(9):666-71. PubMed ID: 20943077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opposing roles of the aldo-keto reductases AKR1B1 and AKR1B10 in colorectal cancer.
    Taskoparan B; Seza EG; Demirkol S; Tuncer S; Stefek M; Gure AO; Banerjee S
    Cell Oncol (Dordr); 2017 Dec; 40(6):563-578. PubMed ID: 28929377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic identification of aldo-keto reductase AKR1B10 induction after treatment of colorectal cancer cells with the proteasome inhibitor bortezomib.
    Loeffler-Ragg J; Mueller D; Gamerith G; Auer T; Skvortsov S; Sarg B; Skvortsova I; Schmitz KJ; Martin HJ; Krugmann J; Alakus H; Maser E; Menzel J; Hilbe W; Lindner H; Schmid KW; Zwierzina H
    Mol Cancer Ther; 2009 Jul; 8(7):1995-2006. PubMed ID: 19567817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulated aldo-keto reductase family 1 member B10 in chronic hepatitis C: association with serum alpha-fetoprotein and hepatocellular carcinoma.
    Sato S; Genda T; Hirano K; Tsuzura H; Narita Y; Kanemitsu Y; Kikuchi T; Iijima K; Wada R; Ichida T
    Liver Int; 2012 Oct; 32(9):1382-90. PubMed ID: 22681639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homeobox A5 activates p53 pathway to inhibit proliferation and promote apoptosis of adrenocortical carcinoma cells by inducing Aldo-Keto reductase family 1 member B10 expression.
    Chen D; Shen Z; Cheng X; Wang Q; Zhou J; Ren F; Sun Y; Wang H; Huang R
    Bioengineered; 2021 Dec; 12(1):1964-1975. PubMed ID: 34027794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statil suppresses cancer cell growth and proliferation by the inhibition of tumor marker AKR1B10.
    Cao Z; Zhou B; Chen X; Huang D; Zhang X; Wang Z; Huang H; Wang Y; Cao D
    Anticancer Drugs; 2014 Sep; 25(8):930-7. PubMed ID: 24800887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.